Cerba Healthcare, headquartered in France, is a leading player in the global healthcare sector, specialising in laboratory services and diagnostics. Founded in 1967, the company has expanded its operations across Europe, Africa, and the Middle East, establishing a strong presence in the medical testing industry.
With a commitment to innovation, Cerba Healthcare offers a comprehensive range of services, including clinical pathology, genetic testing, and specialised diagnostics. Their unique approach combines advanced technology with a patient-centric focus, ensuring high-quality results and rapid turnaround times.
Recognised for its excellence, Cerba Healthcare has achieved significant milestones, positioning itself as a trusted partner for healthcare professionals and institutions. The company’s dedication to precision and reliability has solidified its reputation as a leader in the laboratory services market.
+17 vs industry average
Cerba Healthcare’s score of 39 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Cerba Healthcare?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Health Services has typical carbon intensity
Industry performance
The Health Services industry has increased its overall emissions by 7% since 2019
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Cerba Healthcare's reported carbon emissions
In 2024, Cerba Healthcare reported total carbon emissions of approximately 197.3 million kg CO2e. This figure includes Scope 1 emissions of about 12.8 million kg CO2e, Scope 2 emissions of approximately 3.2 million kg CO2e, and a significant contribution from Scope 3 emissions, which totalled around 181.8 million kg CO2e. Cerba Healthcare has set ambitious climate commitments, aiming for a 42% reduction in CO2 emissions across Scopes 1 and 2 by 2030, compared to 2021 levels. This target reflects a proactive approach to mitigating climate impact and aligns with industry standards for sustainability. Additionally, the company is targeting a 25% reduction in Scope 3 emissions by 2030, further demonstrating its commitment to comprehensive climate action. The emissions data is sourced directly from Cerba HealthCare S.A.S., with no cascading from a parent organization. This ensures that the reported figures accurately reflect the company's own operational impact and climate strategy.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Cerba Healthcare’s Climate Goals (2030 & 2050)
4 goals2030
42% reduction in Scope 2
42% reduction in CO2 emissions for scopes 1 and 2 between 2022 and 2030.
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 4 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Cerba Healthcare
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project